WallStreetZenWallStreetZen

NASDAQ: LYEL
Lyell Immunopharma Inc Stock Forecast, Predictions & Price Target

Analyst price target for LYEL

Based on 1 analyst offering 12 month price targets for Lyell Immunopharma Inc.
Min Forecast
$8.00+180.7%
Avg Forecast
$8.00+180.7%
Max Forecast
$8.00+180.7%

Should I buy or sell LYEL stock?

Based on 1 analyst offering ratings for Lyell Immunopharma Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LYEL stock forecasts and price targets.

LYEL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-09

1 of 1

Forecast return on equity

Is LYEL forecast to generate an efficient return?
Company
-63.55%
Industry
22.06%
Market
28.85%
LYEL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LYEL forecast to generate an efficient return on assets?
Company
-55.76%
Industry
9.33%
LYEL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LYEL revenue forecast

What is LYEL's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$10.0M-79.38%
Avg 2 year Forecast
$10.0M-79.38%
LYEL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LYEL revenue growth forecast

How is LYEL forecast to perform vs Biotechnology companies and vs the US market?
Company
-79.38%
Industry
1,857.96%
Market
51.13%
LYEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LYEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LYEL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LYEL$2.85$8.00+180.70%Buy
SVRA$5.30$7.00+32.08%Strong Buy
YMAB$16.50$21.00+27.27%Buy
NVAX$6.02N/AN/A
EDIT$8.86$14.20+60.27%Strong Buy

Lyell Immunopharma Stock Forecast FAQ

Is Lyell Immunopharma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: LYEL) stock is to Buy LYEL stock.

Out of 1 analyst, 0 (0%) are recommending LYEL as a Strong Buy, 1 (100%) are recommending LYEL as a Buy, 0 (0%) are recommending LYEL as a Hold, 0 (0%) are recommending LYEL as a Sell, and 0 (0%) are recommending LYEL as a Strong Sell.

If you're new to stock investing, here's how to buy Lyell Immunopharma stock.

What is LYEL's revenue growth forecast for 2024-2025?

(NASDAQ: LYEL) Lyell Immunopharma's forecast annual revenue growth rate of -79.38% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 1,857.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 51.13%.

Lyell Immunopharma's revenue in 2024 is $48,503,000.On average, 1 Wall Street analysts forecast LYEL's revenue for 2024 to be $2,518,689,680, with the lowest LYEL revenue forecast at $2,518,689,680, and the highest LYEL revenue forecast at $2,518,689,680.

In 2025, LYEL is forecast to generate $2,518,689,680 in revenue, with the lowest revenue forecast at $2,518,689,680 and the highest revenue forecast at $2,518,689,680.

What is LYEL's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: LYEL) forecast ROA is -55.76%, which is lower than the forecast US Biotechnology industry average of 9.33%.

What is LYEL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year LYEL price target, the average LYEL price target is $8.00, with the highest LYEL stock price forecast at $8.00 and the lowest LYEL stock price forecast at $8.00.

The Wall Street analyst predicted that Lyell Immunopharma's share price could reach $8.00 by Nov 9, 2024. The average Lyell Immunopharma stock price prediction forecasts a potential upside of 180.7% from the current LYEL share price of $2.85.

What is LYEL's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: LYEL) forecast ROE is -63.55%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.